Risk of developing cancer-comparison of HBV, HCV and smoking
Homie Razavi(Center for Disease Analysis), Chris Estes(Center for Disease Analysis), Ivane Gamkrelidze, Kathryn Razavi‐Shearer(Center for Disease Analysis), Alexis Voeller, Sarah Blach(Center for Disease Analysis), Devin Razavi‐Shearer(University of Health Sciences Antigua)
Cited by 0
Related Papers
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
|Hepatology|2017|2.4k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Global epidemiology and genotype distribution of the hepatitis C virus infection
|Journal of Hepatology|2014|1.9k
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664